St. Joseph Medical Group

“Certain listed officers and board members also serve as officers and board members of a taxable entity.”

“Classes of members or stockholders: the filing organization's sole member is penn state health, a pennsylvania nonprofit corporation.”

“Electing members of governing body: directors shall be elected by the corporate member, penn state health. The corporate member may at any time remove, with or without cause, any member of the board of directors.”

“Decisions requiring approval by members or stockholders: pursuant to specifications defined in the bylaws the corporate members have reserved powers. Notwithstanding any other provisions of these bylaws, the sole member must approve the following items, as applicable, before they may be implemented by this corporation. The sole member shall have the authority: (a) to determine the number of and to elect and remove, with or without cause, the directors of the corporation; (b) to appoint and remove, with or without cause, and to determine the compensation of, the president; (c) to elect and remove, with or without cause, the chair and vice chair of the board, the secretary (including any assistant or associate secretary), and the treasurer (including any assistant treasurer); (d) to approve any and all amendments to the articles of incorporation or bylaws of the corporation; (e) to adopt or modify the mission, vision, or objectives of the corporation; (f) to adopt all long-range and strategic plans; (g) to approve all operating and capital budgets; (h) to approve all unbudgeted capital expenditures and all unbudgeted operating expenditures in excess of such amount as is determined by or pursuant to the policies of the sole member; (i) to approve the incurrence of debt or guarantee of indebtedness for borrowed money, or the pledge or mortgage of assets to secure the same and to establish an obligated group for financing purposes; (j) to determine annual distributions to be made to or for the benefit of the pennsylvania state university college of medicine as academic support payments; (k) to require the corporation to participate in a centralized financial and cash management system for penn state health and one or more of its controlled affiliates (the "system"); (l) to approve any donation or transfer of the corporation's assets in excess of such amount as is determined by or pursuant to the policies of the sole member, other than donations or transfers to the sole member or another entity in the system, unless authorized in the corporation's approved budget; (m) to approve and authorize additions and eliminations of clinical services of the corporation and to determine the distribution of clinical and support services across the system; (n) to approve the creation or dissolution of, investment in, or disposition of any subsidiary or joint venture and to approve any other strategic alignment or fundamental change transaction, including (i) joint operating agreements or management agreements, (ii) acquisitions, dispositions or transfers of material operations, (iii) closure of facilities, (iv) mergers, consolidations, and divisions, (v) the sale, pledging, leasing or transfer of assets with a value in excess of such amount as is determined by or pursuant to the policies of the sole member, and (vi) the liquidation or dissolution of the corporation; (o) to adopt employee benefit plans; (p) to adopt or approve the investment policies of the corporation; (q) to select and appoint auditors for, and to designate the fiscal year of, the corporation; (r) to retain counsel on behalf of and settle any litigation against the corporation; (s) to enter into system-wide agreements on behalf of the corporation; and (t) except as otherwise provided in these bylaws, to give such approvals and take such other actions as are specifically reserved to the members of a pennsylvania nonprofit corporation under the pennsylvania nonprofit corporation law of 1988, as amended (the "pennsylvania nonprofit corporation law").”

“Review of form 990 by governing body: the form 990 is prepared by an external accounting firm; it is reviewed by accounting/finance department personnel and the chief financial officer, and then distributed to all members of the board for review and comment before it is filed with the irs.”

“Conflict of interest policy: the filing organization regularly and consistently monitors and enforces compliance with its conflict of interest (coi) policies for officers, directors, and key employees (covered persons). Per the policy, no covered persons may engage in any transaction or arrangement or undertake positions with other organizations that involve a conflict of interest, except in compliance with the policy. Every covered person shall disclose all actual and potential conflicts through an annual written disclosure statement and as matters involving an actual or potential conflict arise. The board will evaluate the disclosures and the material facts relating to the transaction or arrangement giving rise to the potential conflict to determine whether they involve actual conflicts of interest and may attempt to develop alternatives to remove the conflict from the transaction or arrangement. A covered person who has an actual or potential conflict of interest shall not be present for or shall leave any portion of a meeting at which the board of directors or a committee is voting to determine whether a conflict exists, but may be present prior to the vote to make presentation to the board or committee to disclose additional facts, or to respond to questions. The filing organization may enter into a transaction or arrangement in which a covered person has an actual conflict of interest if a majority of directors who have no interest in the transaction or arrangement approve the transaction or arrangement at a board or committee meeting after determining that the transaction or arrangement is fair and reasonable to the corporation, any covered person who has a conflict with respect to the transaction or arrangement does not participate in and is not present for the vote regarding such transaction or arrangement (except that the covered person may appear at a meeting to answer questions), and if the transaction or arrangement involves compensation or other financial benefit to the covered person, the board relies on appropriate comparability data to determine reasonableness. The filing organization will document the foregoing in the minutes of board and committee meetings, as applicable. Each covered person must sign a statement that affirms that he or she has received a copy of the coi policy, has read and understands it, and has agreed to comply with it. If the board of directors has reasonable cause to believe that a covered person has failed to comply with the policy, the board may counsel the covered person regarding such failure and, if the issue is not resolved to the board's satisfaction, may consider additional corrective action, including removal from the board of directors or other position with the filing organization, as appropriate. Form 990, part vi, section b, lines 13 & 14 whistleblower policy and document retention/destruction policy: the filing organization follows the whistleblower policy and document retention and destruction policy of a related organization.”

“Process used to establish compensation of ceo, officers, and key employees: the filing organization is part of a multi-entity health system and may or may not designate one or more of its employees as a ceo (or president), officer, or key employee. If the filing organization does not designate individuals to these roles, the role is handled by an individual from the parent entity, penn state health, or an affilitate. Penn state health has established a system-wide process for establishing compensation as follows: annually, the compensation committee of the parent board engages an independent compensation consultant to conduct a compensation analysis for the organization's chief executive officer (ceo), officers, and key employees. As part of the analysis, the independent compensation consultant identifies, gathers, and analyzes appropriate comparability data upon which the committee and the full board will rely to assess the reasonableness of the total proposed compensation (including benefits) of the ceo, officers, and key employees. Once the compensation analysis is complete and documented in reports, the reports are provided to the board for review and consideration, together with written opinions from the compensation consultant that the proposed compensation arrangements for the ceo, officers, and key employees are reasonable within the meaning of treasury regulation 53.4958-4(b)(1)(ii)(a). With input from the compensation committee, the full board makes annual decisions with respect to compensation for the ceo, officers, and key employees based upon the data in the report and the opinion of the compensation consultant that the proposed compensation is reasonable. These decisions, the basis for these decisions, the board members' names who vote on compensation, and that none of the board members have a conflict of interest with respect to these compensation arrangements is all contemporaneously documented in the minutes.”

“The organization's conflict of interest policy and governing documents are available to the public upon request. The audited consolidated financial statements of the pennsylvania state university and its subsidiaries (which include penn state health) are available at www.psu.edu.”

“Forms 1096: form 1096 for the filing organization is processed and reported by its related organization penn state health (ein: 47-3769205).”

“Physician fees: program service expenses 2,941,881. Total expenses 2,941,881. Contracted staff: program service expenses 788,183. Total expenses 788,183. Other purchased services: program service expenses 769,415. Management and general expenses 137,574. Total expenses 906,989.”